Clinical trials
Carotid Artery Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| John Paul II Hospital, Krakow | 3 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Neuromed IRCCS | 2 |
| Academisch Ziekenhuis Maastricht | 1 |
| Assiut University | 1 |
| Azienda Ospedaliera Ordine Mauriziano di Torino | 1 |
| Azienda Ospedaliera di Perugia | 1 |
| Azienda Ospedaliero, Universitaria Pisana | 1 |
| Diana Gaitini MD. | 1 |
| Elucid Bioimaging Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carotid Artery Diseases | 53 |
| Atherosclerosis | 14 |
| Carotid Stenosis | 12 |
| Stroke | 11 |
| Ischemic Stroke | 4 |
| Vascular Diseases | 4 |
| Coronary Artery Disease | 3 |
| Peripheral Arterial Disease | 3 |
| Plaque, Atherosclerotic | 3 |
| Aortic Aneurysm, Abdominal | 2 |
Trials
Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.